|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
单臂、开放性、多中心临床试验评价人凝血酶原复合物治疗血友病B的有效性和安全性
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B
[Translation] To evaluate the efficacy and safety of human prothrombin complex in the treatment of hemophilia B
100 Clinical Results associated with Sinopharm Guizhou Blood Products Co., Ltd.
0 Patents (Medical) associated with Sinopharm Guizhou Blood Products Co., Ltd.
100 Deals associated with Sinopharm Guizhou Blood Products Co., Ltd.
100 Translational Medicine associated with Sinopharm Guizhou Blood Products Co., Ltd.